India to United States: Diclofenac Export Trade Route
India has recorded 2,120 verified shipments of Diclofenac exported to United States, representing a combined trade value of $98.5M USD. This corridor is served by 34 active Indian exporters, with an average shipment value of $46.5K USD. The leading Indian exporter is RUBICON RESEARCH PRIVATE LIMITED, which accounts for 29% of total export value with 122 shipments worth $28.6M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $17.1M USD in purchases. The top 3 suppliers — RUBICON RESEARCH PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, CIPLA LIMITED — together control 67% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Diclofenac corridor is one of India's established pharmaceutical export routes, with 2,120 shipments documented worth a combined $98.5M USD. The route is dominated by RUBICON RESEARCH PRIVATE LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's diclofenac manufacturing sector.
Across 34 active suppliers, the average shipment value stands at $46.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with diclofenac's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #4 among India's top diclofenac export destinations globally.
On the import side, key buyers of Indian diclofenac in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, DR. REDDY'S LABORATORIES, INC, RELIABLE HEALTHCARE LOGISTICS LLC and 120 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 860 shipments valued at $17.1M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ4
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#4
- Annual growth+30.2%
- Demand growth+25.2%
- Regulatory ease76/100
Top 10 Indian Diclofenac Exporters to United States
Showing top 10 of 34 Indian suppliers exporting Diclofenac to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RUBICON RESEARCH PRIVATE LIMITED Avg $234.3K per shipment | 122 | $28.6M | 29.0% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $46.9K per shipment | 415 | $19.4M | 19.7% |
| 3 | CIPLA LIMITED Avg $20.1K per shipment | 906 | $18.2M | 18.5% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED Avg $161.7K per shipment | 40 | $6.5M | 6.6% |
| 5 | ENCUBE ETHICALS PRIVATE LIMITED Avg $62.8K per shipment | 99 | $6.2M | 6.3% |
| 6 | DR REDDYS LABORATORIES LIMITED Avg $59.8K per shipment | 98 | $5.9M | 6.0% |
| 7 | RUBICON RESEARCH LIMITED Avg $120.6K per shipment | 20 | $2.4M | 2.4% |
| 8 | DR.REDDY'S LABORATORIES LIMITED Avg $48.5K per shipment | 43 | $2.1M | 2.1% |
| 9 | J B CHEMICALS AND PHARMACEUTICALS LIMITED Avg $13.7K per shipment | 137 | $1.9M | 1.9% |
| 10 | DR REDDY S LABORATORIES LTD Avg $48.2K per shipment | 24 | $1.2M | 1.2% |
This table shows the top 10 of 34 Indian companies exporting diclofenac to United States, ranked by total trade value. The listed exporters are: RUBICON RESEARCH PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, CIPLA LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ENCUBE ETHICALS PRIVATE LIMITED, DR REDDYS LABORATORIES LIMITED, RUBICON RESEARCH LIMITED, DR.REDDY'S LABORATORIES LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED, DR REDDY S LABORATORIES LTD. RUBICON RESEARCH PRIVATE LIMITED is the dominant supplier with 122 shipments worth $28.6M USD, giving it a 29% market share. The top 3 suppliers together account for 67% of the total trade value on this route.
Showing top 10 of 34 total Indian exporters on the India to United States Diclofenac export route.
Top 10 Diclofenac Importers in United States
Showing top 10 of 123 known buyers in United States receiving Diclofenac shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian diclofenac in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, DR. REDDY'S LABORATORIES, INC, RELIABLE HEALTHCARE LOGISTICS LLC, TRIFLUENT PHARMA, EVERSANA LIFE SCIENCES SERVICES LLC, among 123 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $17.1M USD across 860 shipments — representing 17% of all diclofenac imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 860 | $17.1M | 17.4% |
| 2 | DR. REDDY'S LABORATORIES, INC | 357 | $16.6M | 16.8% |
| 3 | RELIABLE HEALTHCARE LOGISTICS LLC | 4 | $14.3M | 14.5% |
| 4 | TRIFLUENT PHARMA | 21 | $6.5M | 6.6% |
| 5 | EVERSANA LIFE SCIENCES SERVICES LLC | 59 | $4.0M | 4.1% |
| 6 | DR REDDY SLABORATORIES INC | 67 | $3.9M | 4.0% |
| 7 | J KNIPPER COMPANY | 17 | $3.2M | 3.2% |
| 8 | DR REDDY S LABORATORIES INC | 50 | $3.0M | 3.1% |
| 9 | J. KNIPPER & COMPANY | 13 | $2.2M | 2.3% |
| 10 | DR. REDDY'S LABORATORIES INC | 42 | $2.0M | 2.1% |
Showing top 10 of 123 Diclofenac importers in United States on this route.
Top 10 Diclofenac Formulations Imported by United States
Showing top 10 of 768 product formulations shipped on the India to United States Diclofenac route, ranked by trade value
United States imports a wide range of diclofenac formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DICLOFENAC SODIUM DELAYED RELEASE TABLETS USP 25MG [100'S TABS PER BOTTLE] (BATCH NO. 30064HF1) — accounts for $7.0M USD across 1 shipments. There are 768 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DICLOFENAC SODIUM DELAYED RELEASE TABLETS USP 25MG [100'S TABS PER BOTTLE] (BATCH NO. 30064HF1) | 1 | $7.0M | 7.1% |
| 2 | DICLOFENAC SODIUM DELAYED RELEASE TABLETS USP 25MG [100'S TABS PER BOTTLE] (BATCH NO. 30100HF1) | 1 | $7.0M | 7.1% |
| 3 | DICLOFENAC SODIUM TOPICAL GEL 1%W/W NDC NO.69097-524-44 ANDA NO. 209903 | 157 | $3.2M | 3.3% |
| 4 | 300036534 Diclofenac Sodium Topical Gel1% 100gm(OTC CL LAMI) | 18 | $3.1M | 3.1% |
| 5 | DICLOFENAC SODIUM TOPICAL GEL, 1%W/W NDC NO.69097-524-44 ANDA NO. 209903 | 103 | $2.1M | 2.1% |
| 6 | DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 10 | 32 | $2.1M | 2.1% |
| 7 | DICLOFENAC SODIUM TOPICAL GEL 1 W W NDC NO 69097 524 44 ANDA NO 209903 | 77 | $1.6M | 1.6% |
| 8 | DICLOFENAC POTASSIUM TABLETS USP 25MG [3 | 1 | $1.1M | 1.1% |
| 9 | 300102420 Diclofenac Sodium Topical Gel1%100gm (Bluepoint) | 6 | $1.0M | 1.0% |
| 10 | DICLOFENAC POTASSIUM TABLETS USP 25MG [30'S TABS PER BOTTLE] BATCH NO. 31173HC1 | 1 | $1.0M | 1.0% |
Showing top 10 of 768 Diclofenac formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 646 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's diclofenac exports to United States are driven primarily by a handful of large-scale manufacturers. RUBICON RESEARCH PRIVATE LIMITED with 122 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 34 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — RUBICON RESEARCH PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, CIPLA LIMITED — together account for 67% of total trade value on this route. The average shipment value of $46.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as diclofenac sodium delayed release tablets usp 25mg [100's tabs per bottle] (batch no. 30100hf1) and diclofenac sodium topical gel 1%w/w ndc no.69097-524-44 anda no. 209903, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 860 shipments worth $17.1M USD — representing 17% of all diclofenac imports from India on this route. A total of 123 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $98.5M
- Avg. Shipment
- $46.5K
- Suppliers
- 34
- Buyers
- 123
- Transit (Sea)
- ~22 days
- Annual Growth
- +30.2%
Related Analysis
Reverse Direction
United States → India — Diclofenac (Import)Other Diclofenac Routes
Unlock the Full India to United States Diclofenac Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2,120 shipments on this route.
Frequently Asked Questions — India to United States Diclofenac Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Diclofenac to United States?
The leading Indian exporters of Diclofenac to United States are RUBICON RESEARCH PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, CIPLA LIMITED. RUBICON RESEARCH PRIVATE LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Diclofenac exports from India to United States?
India exports Diclofenac to United States worth approximately $98.5M USD across 2,120 recorded shipments. The average value per shipment is $46.5K USD.
Q Which ports does India use to ship Diclofenac to United States?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 646 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to United States for Diclofenac?
The average transit time for Diclofenac shipments from India to United States is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Diclofenac trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.2% with demand growth tracking at 25.2%. The route is ranked #4 among India's top Diclofenac export destinations globally.
Q How many suppliers are active on the India to United States Diclofenac route?
There are currently 34 active Indian suppliers exporting Diclofenac to United States. The market is moderately concentrated with RUBICON RESEARCH PRIVATE LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Diclofenac from India in United States?
The leading importers of Indian Diclofenac in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, DR. REDDY'S LABORATORIES, INC, RELIABLE HEALTHCARE LOGISTICS LLC, TRIFLUENT PHARMA, EVERSANA LIFE SCIENCES SERVICES LLC. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 860 shipments worth $17.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Diclofenac.
- 2.Supplier/Buyer Matching: 34 Indian exporters and 123 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2,120 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,120 Verified Shipments
34 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists